ACBM — Acro Biomedical Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro Cap

Annual balance sheet for Acro Biomedical Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 September 30th	2019 September 30th	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.001	0.001	0.018	0.095	0.006
Net Total Accounts Receivable
Net Total Receivables	—	—	—	0.598	0.638
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1.48	1.07	0.973	0.706	0.658
Net Property, Plant And Equipment	—	—	0.025	0.05	0.026
Other Long Term Assets
Total Assets	1.48	1.07	0.998	0.761	0.687
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.241	0.196	0.312	0.092	0.201
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.241	0.196	0.312	0.117	0.201
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Total Equity	1.24	0.874	0.686	0.644	0.486
Total Liabilities & Shareholders' Equity	1.48	1.07	0.998	0.761	0.687
Total Common Shares Outstanding